Media
Femasys in the
Femasys in the
conversation.
Podcasts, press coverage, educational videos, webinars, blog posts, and press resources — everything you need to stay current on Femasys and our women’s health innovations.
Featured
News
August 2026
Femasys Secures $30 Million Private Placement, with Potential Proceeds of Up to $90 Million
Feb 28, 2024
Femasys’ FemaSeed FDA Clearance Brings Timely Access to a First-Line Infertility Treatment Option as an Alternative to IVF
GlobeNewswire
Read ↗
Feb 6, 2024
Femasys Inc. Advances Commercial Readiness with Appointment of Richard Spector to New Position of Chief Commercial Officer
GlobeNewswire
Read ↗
Jan 26, 2024
Femasys Inc. Begins FemBloc Pivotal Trial Enrollment at UC Davis Medical Center, a Hub for Innovation and Groundbreaking Research in Health Care for Women
GlobeNewswire
Read ↗
Jan 23, 2024
Femasys Inc. Begins FemBloc Pivotal Trial Enrollment at University of Utah, an Internationally Recognized Center in Obstetrics and Gynecology
GlobeNewswire
Read ↗
Dec 15, 2023
Femasys Inc. Begins FemBloc Pivotal Trial Enrollment at Stanford Medicine
GlobeNewswire
Read ↗
Nov 30, 2023
Femasys Inc. Announces the Appointment of James Liu, M.D., as Chief Medical Officer
GlobeNewswire
Read ↗
Stay Current
Women’s health news, delivered.
Get the latest Femasys updates — from progress on FemaSeed® fertility commercialization and the FemBloc® U.S. clinical trial to educational events and press releases — delivered directly to your inbox.
You can unsubscribe from these communications at any time.
For more information on our privacy practices, and how we are committed to protecting and respecting your privacy, please review our Privacy Policy.